Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02230801n
Noun Concept
Categories: Breakthrough therapy, Pfizer brands, Drugs acting on the nervous system, Orphan drugs
EN
tafamidis  2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid  ATC code N07XX08  ATCvet code QN07XX08  FX-1006
EN
Tafamidis, sold under the brand names Vyndaqel and Vyndamax, is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis. Wikipedia
Definitions
Relations
Sources
EN
Tafamidis, sold under the brand names Vyndaqel and Vyndamax, is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis. Wikipedia
Chemical compound Wikidata
A drug for the amelioration of transthyretin-related hereditary amyloidosis. Wiktionary
IS A
compound
medicine
PHYSICALLY INTERACTS WITH
transthyretin
Wikipedia
EN
tafamidis
Wikidata
EN
tafamidis
Wiktionary
EN
tafamidis
Wikipedia Redirections
EN
ATC code N07XX08, ATCvet code QN07XX08, FX-1006A, tafamidis meglumine, Vyndamax, Vyndaqel
Wikidata Alias
EN
FX-1006, Tafamidis, tafamidisum, 2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License